Ocrevus

MS Group Praises New Drug Despite High Price Tag
MS Group Praises New Drug Despite High Price TagWhy a drug that costs $65,000 a year is making patient groups happy.
First progressive MS drug carries high price tagWhile FDA just approved the first drug for primary progressive multiple sclerosis (PPMS), the drug’s price tag is controversial.
Why 2016 drug approvals fell
Why 2016 drug approvals fellWhile FDA approved far fewer new drugs in 2016 than 2015, the agency quickly approved novel and breakthrough therapies.
Three drug trends impacting specialty pharmacyAMCP session, “Specialty Pharmaceutical in Development,” highlighted critical trends that healthcare executives should be watching